Company Filing History:
Years Active: 2021-2022
Title: C Garrett Rappazzo: Innovator in Coronavirus Research
Introduction
C Garrett Rappazzo is a notable inventor based in Lebanon, NH (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds specific to the coronavirus S protein. With a total of 3 patents, Rappazzo's work is crucial in the ongoing fight against viral diseases.
Latest Patents
Rappazzo's latest patents focus on antibodies and antigen binding fragments that exhibit binding specificity for the S protein of coronaviruses, including SARS-CoV and SARS-CoV-2. These patents detail the development of neutralizing antibodies and conjugates of anti-CoV-S antibodies, which can be used for the diagnosis, assessment, and treatment of diseases associated with coronaviruses. The methods outlined in these patents aim to provide therapeutic and prophylactic benefits in combating these viral infections.
Career Highlights
C Garrett Rappazzo is currently associated with Adagio Therapeutics, Inc., where he continues to advance his research in the field of immunology and virology. His innovative approaches have positioned him as a key player in the development of therapeutic solutions for coronavirus-related diseases.
Collaborations
Rappazzo collaborates with esteemed colleagues, including Laura M Walker and Laura Deveau, to further enhance the impact of his research. Their combined expertise contributes to the advancement of therapeutic strategies in the fight against viral infections.
Conclusion
C Garrett Rappazzo's work exemplifies the importance of innovation in addressing global health challenges. His contributions to coronavirus research are vital for developing effective treatments and diagnostics.